Construction and characterization of polycistronic retrovirus vectors for sustained and high-level co-expression of apolipoprotein A-I and lecithin-cholesterol acyltransferase

Atherosclerosis

Volumn 147, Issue 1, 1999, Pages 139-145

  Fan, Leming ^a,b   Owen, James S ^c   Dickson, George ^a  

^a UNIVERSITY OF LONDON   (United Kingdom)

^b NANJING MEDICAL UNIVERSITY   (China)

^c ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

Atherosclerosis; Cholesterol; Gene delivery; High density lipoproteins; Retroviral vectors; Skeletal muscle

Indexed keywords

APOLIPOPROTEIN A1; CHOLESTEROL; COMPLEMENTARY DNA; DNA; HIGH DENSITY LIPOPROTEIN; KANAMYCIN KINASE; PHOSPHATIDYLCHOLINE STEROL ACYLTRANSFERASE; VIRUS VECTOR;

ANIMAL CELL; ARTICLE; ATHEROSCLEROSIS; EMBRYO; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE; GENE EXPRESSION; GENE TARGETING; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RETROVIRUS; SKELETAL MUSCLE;

ANIMALS; APOLIPOPROTEIN A-I; ARTERIOSCLEROSIS; CELL LINE; CELLS, CULTURED; GENE EXPRESSION; GENE THERAPY; GENES, VIRAL; GENETIC VECTORS; HUMANS; KANAMYCIN KINASE; KIDNEY; MICE; MUSCLE, SKELETAL; PHOSPHATIDYLCHOLINE-STEROL O-ACYLTRANSFERASE; RETROVIRIDAE; TRANSFECTION; VIRAL STRUCTURAL PROTEINS;

EID: 0032883857     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(99)00191-4     Document Type: Article

References (51)

1. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature. 362:1993;801-808.
2. Brown M.S., Goldstein J.L. A receptor-mediated pathway for cholesterol homeostasis. Science. 232:1986;34-47.
3. Krieger M., Herz J. Structures and functions of multiligand lipoprotein receptors: macrophage scavenger receptors and LDL receptor-related protein (LRP). Annu Rev Biochem. 63:1994;601-637.
4. von Eckardstein A. Cholesterol efflux from macrophages and other cells. Curr Opin Lipidol. 7:1996;308-319.
5. Fielding C.J., Fielding P.E. Intracellular cholesterol transport. J Lipid Res. 38:1997;1503-1521.
6. Miller N.E. Associations of high-density lipoprotein subclasses and apolipoproteins with ischemic heart disease and coronary atherosclerosis. Am Heart J. 113:1987;589-595.
7. Cockerill G.W., Rye K.A., Gamble J.R., Vadas M.A., Barter P.J. High-density lipoproteins inhibit cytokine-induced expression of endothelial cell adhesion molecules. Arterioscler Thromb Vasc Biol. 15:1995;1987-1994.
8. Graham A., Rafique S., Hassall D.G., Owen J.S. Paraoxonase-independent inhibition of low-density lipoprotein oxidation by high-density lipoprotein. Atherosclerosis. 135:1997;193-204.
9. Fielding C.J., Fielding P.E. Molecular physiology of reverse cholesterol transport. J Lipid Res. 36:1995;229-240.
10. Gjone E., Norum K.R., Glomset J.A. Familial lecithin:cholesterol acyltransferase deficiency. Stanbury J.B., Wyngaarden J.B., Fredrickson D.S. The Metabolic Basis of Inherited Disease. 1983;589-603 McGraw-Hill, New York.
11. +-dependent D-glucose transport and altered lipid composition in renal cortical brush-border membrane vesicles from bile-duct ligated rats. J Lipid Res. 33:1992;473-483.
12. Applebaum-Bowden D. Lipases and lecithin:cholesterol acyltransferase in the control of lipoprotein metabolism. Curr Opin Lipidol. 6:1995;130-135.
13. Miyazaki A., Sakuma S., Morikawa W. et al. Intravenous injection of rabbit apolipoprotein A-I inhibits the progression of atherosclerosis in cholesterol-fed rabbits. Arterioscler Thromb Vasc Biol. 15:1995;1882-1888.
14. Koizumi J., Kano M., Okabayashi K., Jadhav A., Thompson G.R. Behaviour of human apolipoprotein A-I:phospholipid and apoHDL:phospholipid complexes in vitro and after injection into rabbits. J Lipid Res. 29:1988;1405-1415.
15. Rubin E.M., Krauss R.M., Spangler E.A., Verstuyft J.E., Clift S.M. Inhibition of early atherogenesis in transgenic mice by human apolipoprotein A-I. Nature. 353:1993;265-267.
16. Hoeg J.M., Santamarina-Fojo S., Bérard A.M. et al. Overexpression of lecithin-cholesterol acyltransferase in transgenic rabbits prevents diet-induced atherosclerosis. Proc Natl Acad Sci USA. 93:1996;11448-11453.
17. Plump A.S., Scott C.J., Breslow J.L. Human apolipoprpotein A-I gene expression increases high density lipoprotein and suppresses atherosclerosis in the apolipoprotein E-deficient mouse. Proc Natl Acad Sci USA. 91:1994;9607-9611.
18. Brousseau M.E., Wang J., Demosky S.J. Jr. et al. Correction of hypoalphalipoproteinemia in LDL receptor-deficient rabbits by lecithin:cholesterol acyltransferase. J Lipid Res. 39:1998;1558-1567.
19. Liu A.C., Lawn R.M., Versuyft J.G., Rubin E.M. Human apolipoprotein A-I gene prevents atherosclerosis associated with apolipoprotein (a) in transgenic mice. J Lipid Res. 35:1994;2263-2267.
20. Breslow J.L., Ross D., Mcpherson J. et al. Isolation and characterization of cDNA clones for human apolipoprotein A-I. Proc Natl Acad Sci USA. 79:1992;6861-6865.
21. Adam M.A., Ramesh N., Miller A.D., Osborne W.R.A. Internal initiation of translation in retrovirus vectors carrying picornavirus regions. J Virol. 65:1991;4985-4990.
22. Palmer T.D., Miller A.D., Reeder R.H., McStay B. Efficient expression of a protein coding gene under the control of an RNA polymerase I promoter. Nucl Acids Res. 21:1993;3451-3457.
23. McLean J., Fielding C., Drayna D. et al. Cloning and expression of human lecithin-cholesterol acyltransferase cDNA. Proc Natl Acad Sci USA. 83:1986;2335-2339.
24. Markowitz D., Hesdorffer C., Ward M., Goff S., Bank A. Retroviral gene transfer using safe and efficient packaging cell lines. Ann New York Acad Sci. 612:1990;407-414.
25. Gillett M.P.T., Owen J.S. Cholesterol esterifying enzymes - lecithin:cholesterol acyltransferase (LCAT) and acylcoenzyme A:cholesterol acyltransferase (ACAT). Converse C., Skinner R.E. Lipoprotein Analysis. 1992;187-201 IRL Press, Oxford.
26. Chen C.-H., Albers J.J. Characterization of proteoliposomes containing apoprotein A-I: a new substrate for the measurement of lecithin:cholesterol acyltransferase activity. J Lipid Res. 23:1982;680-691.
27. Chawla D., Owen J.S. Secretion of active lecithin-cholesterol acyltransferase by insect cells infected with a recombinant baculovirus. Biochem J. 309:1995;249-253.
28. 6-tagged lecithin-cholesterol acyltransferase (LCAT) is catalytically active. Biochem Soc Trans. 26:1998;146.
29. Sambrook J., Fritsch E.F., Maniatis T. Molecular Cloning: A Laboratory Manual. 1989;14-22 Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
30. Deglon N., Heyd B., Tan S.A., Joseph J.M., Zurn A.D., Aebischer P. Central nervous system delivery of recombinant ciliary neurotropic factor by polymer encapsulated differentiated C2C12 myoblasts. Hum Gene Ther. 7:1996;2135-2146.
31. Meng Q.-H., Calabresi L., Fruchart J.-C., Marcel Y.L. Apolipoprotein A-I domains involved in the activation of lecithin:cholestrol acyltransferase. Importance of the central domain. J Biol Chem. 268:1993;16966-16973.
32. Leroy A., Dallongeville J., Fruchart J.-C. Apolipoprotein AI-containing lipoproteins and atherosclerosis. Curr Opin Lipidol. 6:1995;281-285.
33. Vaisman V.L., Klein H.-G., Rouis M. et al. Overexpression of human lecithin-cholesterol acyltransferase leads to hyperalphalipoproteinemia in transgenic mice. J Biol Chem. 270:1995;12269-12275.
34. Francone O.L., Gong E.L., Ng D.S., Fielding C.J., Rubin E.M. Expression of human lecithin-cholesterol acyltransferase in transgenic mice. Effect of human apolipoprotein AI and human apolipoprotein AII on plasma lipoprotein cholesterol metabolism. J Clin Invest. 96:1995;1440-1448.
35. Mehlum A., Staels B., Duverger N. et al. Tissue-specific expression of the human gene for lecithin:cholesterol acyltransferase in transgenic mice alters blood lipids lipoproteins and lipases towards a less atherogenic profile. Eur J Biochem. 230:1995;567-575.
36. Föger B., Vaisman B.L., Paigen B., Hoyt R.F., Brewer H.B., Santamarina-Fojo S. CETP modulates the development of aortic atherosclerosis in LCAT-transgenic mice. Circulation. 96:1997;1-110.
37. Gerard R.D., Chan L. Adenovirus-mediated gene transfer: strategies and applications in lipoprotein research. Curr Opin Lipidol. 7:1996;105-111.
38. Kopfler W.P., Willard M., Betz T., Willard J.E., Gerard R.D., Meidell R.S. Adenovirus-mediated transfer of a gene encoding human apolipoprotein A-I into normal mice increases circulating high-density lipoprotein cholesterol. Circulation. 90:1994;1319-1327.
39. Seguret-Mace S., Latta-Mahieu M., Castro G. et al. Potential gene therapy for lecithin-cholesterol acyltransferase (LCAT)-deficient and hypoalphalipoproteinemic patients with adenovirus-mediated transfer of human LCAT gene. Circulation. 94:1996;2177-2184.
40. Svensson E.C., Tripathy S.K., Leiden J.M. Muscle-based gene therapy: realistic possibilities for the future. Mol Med Today. 2:1996;166-172.
41. Dickson G. Gene transfer to muscle. Biochem Soc Trans. 24:1996;513-519.
42. Decary S., Mouly V., Hamida C.B., Sautet A., Barbet J.P., Butler-Brewne G.S. Replicative potential and telomere length in human skeletal muscle: implications for satellite cell-mediated gene therapy. Hum Gene Ther. 8:1997;1429-1438.
43. Dhawan J., Pan L.C., Pavlath G.K. Systemic delivery of human growth hormone by injection of genetically engineered myoblasts. Science. 254:1991;1509-1512.
44. Fassati A., Wells D.J., Walsh F.S., Dickson G. Transplantation of retroviral producer cells for in vivo gene transfer into skeletal muscle. Hum Gene Ther. 7:1996;595-602.
45. Law P.K., Goodwin T.G., Fang Q. et al. Human gene therapy with myoblast transfer. Transplant Proc. 29:1997;2234-2237.
46. Yao S.-N., Kurachi K. Implanted myoblasts not only fuse with myoblasts but also survive as muscle precursor cells. J Cell Sci. 105:1993;957-963.
47. Hawley R.G. Therapeutic potential of retroviral vectors. Transfus Sci. 17:1996;7-14.
48. Emerman M., Temin H.M. Genes with promoters in retrovirus vectors can be independently suppressed by an epigenetic mechanism. Cell. 39:1984;459-467.
49. Jang S.K., Krausslich H.-G., Nicklin M.J.H., Duke G.M., Palmenberg A.C., Wimmer E. A segment of the 5′ nontranslated region of encephalomyocarditis virus RNA directs internal entry of ribosomes during in vivo translation. J Virol. 62:1988;2636-2643.
50. Jang S.K., Davies M.V., Kaujman R.J., Wimmer E. Initiation of protein synthesis by internal entry of ribosomes into the 5′ nontranslated region of encephalomyocarditis virus RNA in vivo. J Virol. 63:1989;1651-1660.
51. Pelletier J., Sonenberg N. Internal binding of eucaryotic ribosomes on poliovirus RNA: translation in HeLa cell extracts. J Virol. 63:1989;441-444.